CSL · 2 days ago
FLQA Specialist
CSL Seqirus is a leading provider of influenza vaccines, dedicated to protecting communities from seasonal influenza and global pandemic threats. The FLQA Specialist will apply quality principles related to equipment qualification and validation, ensuring compliance with cGMP and regulatory requirements while providing technical support and oversight in various operational areas.
BiotechnologyHealth CareHealth DiagnosticsMedical
Responsibilities
Ensure that qualification, validation, and technical protocols, and reports comply with site SOPs. Provide review and approval of related documents
Provide QA oversight to equipment qualification, technical transfers, process, method, cleaning and computer system validation including revalidation and re-evaluation
Maintain audit program, reviewing functional and release documentation, and reviewing and approving deviation investigations relevant to area(s) of responsibility
Review lot release documentation and Facilitate compliant release process for corresponding market
Respond to questions from authorities (Swissmedic, FDA, etc.) to ensure timely product release
Ensure standard operating procedures (SOP's) stay current and align with corporate and regulatory requirements
Interface with customers and partners on quality related issues
Execute training/awareness related to GMP standards
Provide training on quality concepts and tools
Qualification
Required
University degree in a relevant scientific discipline (Pharmacy, Chemistry, Biology, Biochemistry)
3+ years' GMP experience in pharmaceutical/biotech or other regulated industry
Knowledge of current Good Manufacturing Practices (cGMP) principles
Knowledge of FDA and EMA requirements
Company
CSL
CSL develops innovative biotherapies and influenza vaccines that save lives, and help people with life-threatening medical conditions.
Funding
Current Stage
Public CompanyTotal Funding
$111M2013-12-20Acquired
2004-02-06Post Ipo Equity· $111M
1994-06-03IPO
Recent News
Pharma Letter
2026-01-03
2025-10-29
Company data provided by crunchbase